This is wonderful news regarding new treatment options for the SD community.

Read the full press release from Novartis: www.novartis.com/news/media-r...

#ChronicHives #Urticaria #Allergy #Dermatology #BTKinhibitor #SD

#Novartis' oral #BTKinhibitor #Rhapsido has had its label expanded in the #US to include ​a second indication, #symptomaticdermographism (SD), which causes #chronichives.

pharmaphorum.com/news/rhapsid...